Výsledek obrázku pro rituximab mechanism of action | Reumatologia
Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies | Clinical Cancer Research
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Empowering Targeted Therapy: Lessons from Rituximab | Science Signaling
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma - Annals of Oncology
Schematic illustration of the mechanism of action of rituximab. The... | Download Scientific Diagram
Current perspective on rituximab in rheumatic diseases | DDDT
The value of rituximab treatment in primary Sjögren's syndrome - ScienceDirect
A tale of two antibodies: obinutuzumab versus rituximab - Freeman - 2018 - British Journal of Haematology - Wiley Online Library
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
Rituximab | Immunopaedia
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Immunosuppressive therapy with rituximab in common variable immunodeficiency | SpringerLink
Rituximab mechanisms of action; the three major independent mechanisms... | Download Scientific Diagram
PLOS ONE: Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Obinutuzumab for the treatment of non-Hodgkin lymphomas
Efficacy and Toxicity of Rituximab in Multiple Sclerosis | Archives of Neuroscience | Full Text
